These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 29554204)

  • 1. CD8+ T-cell exhaustion in cancer: mechanisms and new area for cancer immunotherapy.
    He QF; Xu Y; Li J; Huang ZM; Li XH; Wang X
    Brief Funct Genomics; 2019 Mar; 18(2):99-106. PubMed ID: 29554204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of Cbl-b inhibits CD8
    Kumar J; Kumar R; Kumar Singh A; Tsakem EL; Kathania M; Riese MJ; Theiss AL; Davila ML; Venuprasad K
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell exhaustion and immune-mediated disease-the potential for therapeutic exhaustion.
    McKinney EF; Smith KG
    Curr Opin Immunol; 2016 Dec; 43():74-80. PubMed ID: 27744240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting PD-1 and Tim-3 Pathways to Reverse CD8 T-Cell Exhaustion and Enhance Ex Vivo T-Cell Responses to Autologous Dendritic/Tumor Vaccines.
    Liu J; Zhang S; Hu Y; Yang Z; Li J; Liu X; Deng L; Wang Y; Zhang X; Jiang T; Lu X
    J Immunother; 2016 May; 39(4):171-80. PubMed ID: 27070448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy.
    Jiang W; He Y; He W; Wu G; Zhou X; Sheng Q; Zhong W; Lu Y; Ding Y; Lu Q; Ye F; Hua H
    Front Immunol; 2020; 11():622509. PubMed ID: 33633741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8
    Zhang B; Liu J; Mo Y; Zhang K; Huang B; Shang D
    Front Immunol; 2024; 15():1476904. PubMed ID: 39372416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Levels of Eomes Promote Exhaustion of Anti-tumor CD8
    Li J; He Y; Hao J; Ni L; Dong C
    Front Immunol; 2018; 9():2981. PubMed ID: 30619337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exhaustion-associated regulatory regions in CD8
    Mognol GP; Spreafico R; Wong V; Scott-Browne JP; Togher S; Hoffmann A; Hogan PG; Rao A; Trifari S
    Proc Natl Acad Sci U S A; 2017 Mar; 114(13):E2776-E2785. PubMed ID: 28283662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reinvigorating exhausted CD8
    Hossain MA; Liu G; Dai B; Si Y; Yang Q; Wazir J; Birnbaumer L; Yang Y
    Med Res Rev; 2021 Jan; 41(1):156-201. PubMed ID: 32844499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8
    Seo H; Chen J; González-Avalos E; Samaniego-Castruita D; Das A; Wang YH; López-Moyado IF; Georges RO; Zhang W; Onodera A; Wu CJ; Lu LF; Hogan PG; Bhandoola A; Rao A
    Proc Natl Acad Sci U S A; 2019 Jun; 116(25):12410-12415. PubMed ID: 31152140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-infiltrating CD8
    Kumar S; Singh SK; Rana B; Rana A
    Drug Discov Today; 2021 Apr; 26(4):951-967. PubMed ID: 33450394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cytotoxic T lymphocytes: role in immunosurveillance and in immunotherapy].
    Benchetrit F; Gazagne A; Adotevi O; Haicheur N; Godard B; Badoual C; Fridman WH; Tartour E
    Bull Cancer; 2003; 90(8-9):677-85. PubMed ID: 14609756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-resident CD8+ T-cell: the critical catalyst in IL-12-mediated reversal of tumor immune suppression.
    Egilmez NK; Kilinc MO
    Arch Immunol Ther Exp (Warsz); 2010 Dec; 58(6):399-405. PubMed ID: 20872283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral Tcf1
    Siddiqui I; Schaeuble K; Chennupati V; Fuertes Marraco SA; Calderon-Copete S; Pais Ferreira D; Carmona SJ; Scarpellino L; Gfeller D; Pradervand S; Luther SA; Speiser DE; Held W
    Immunity; 2019 Jan; 50(1):195-211.e10. PubMed ID: 30635237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-resident memory T cells in tumor immunity and immunotherapy.
    Okła K; Farber DL; Zou W
    J Exp Med; 2021 Apr; 218(4):. PubMed ID: 33755718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exhaustion and senescence: two crucial dysfunctional states of T cells in the tumor microenvironment.
    Zhao Y; Shao Q; Peng G
    Cell Mol Immunol; 2020 Jan; 17(1):27-35. PubMed ID: 31853000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8
    Huang Y; Jia A; Wang Y; Liu G
    Immunology; 2023 Jan; 168(1):30-48. PubMed ID: 36190809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic and spatial heterogeneity of CD8
    Sun Y; Yinwang E; Wang S; Wang Z; Wang F; Xue Y; Zhang W; Zhao S; Mou H; Chen S; Jin L; Li B; Ye Z
    Mol Cancer; 2024 Sep; 23(1):193. PubMed ID: 39251981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-inhibitory Molecule B7 Superfamily Member 1 Expressed by Tumor-Infiltrating Myeloid Cells Induces Dysfunction of Anti-tumor CD8
    Li J; Lee Y; Li Y; Jiang Y; Lu H; Zang W; Zhao X; Liu L; Chen Y; Tan H; Yang Z; Zhang MQ; Mak TW; Ni L; Dong C
    Immunity; 2018 Apr; 48(4):773-786.e5. PubMed ID: 29625896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into T-cell exhaustion in liver cancer: from mechanism to therapy.
    Hao L; Li S; Hu X
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12543-12560. PubMed ID: 37423958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.